DelfaGLP-1 Atlas

Lead sponsor

Washington University School of Medicine

5 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

5

Trials led

2

Active

150

Total enrollment

4

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
1
Phase 2
2
Phase 4
1
Not applicable
1

Trials by status

Recruiting
2
Completed
1
Withdrawn
2

Trials led

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease—Ph 2Recruiting60
The Effects of Bethanechol on Glucose HomeostasisHbA1c ≤9%Ph 1Completed50
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With ObesityBMI ≥30not applicableRecruiting40
TRZBMI 30-42Ph 4Withdrawnnot disclosed
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaBMI ≥30Ph 2Withdrawnnot disclosed